Analyze 5 years of NEET PG question papers Return: Top 10 recurring topics with counts. Top 5 topics most likely for the next exam with confidence % each. For each top topic, list 1 common question type."
NEET PG question paper topic frequency analysis 2020 2021 2022 2023 2024 recurring topics
NEET PG 2024 2023 most repeated topics subject wise analysis high yield topics
NEET PG previous year question papers topic distribution analysis medicine surgery anatomy
https://reflexprep.com/blog/neet-pg-pyq-analysis-last-5-year…
| Rank | Topic | Years Appeared | Frequency Count* | Subject Area |
|---|---|---|---|---|
| 1 | Acute Coronary Syndrome (ACS/STEMI/NSTEMI) | 2021, 2022, 2023, 2024, 2025 | 5/5 | Medicine |
| 2 | Diabetes Mellitus & Complications | 2021, 2022, 2023, 2024, 2025 | 5/5 | Medicine |
| 3 | Tuberculosis (NTEP, MDR-TB, drug regimens) | 2021, 2022, 2023, 2024, 2025 | 5/5 | Medicine / Microbiology |
| 4 | Pre-eclampsia / Eclampsia Management | 2021, 2022, 2023, 2024, 2025 | 5/5 | OBG |
| 5 | Postpartum Haemorrhage (PPH) | 2021, 2022, 2023, 2024, 2025 | 5/5 | OBG |
| 6 | Epidemiology & Study Designs (PSM) | 2021, 2022, 2023, 2024, 2025 | 5/5 | Community Medicine |
| 7 | Acute Kidney Injury / CKD | 2021, 2022, 2023, 2024, 2025 | 5/5 | Medicine / Nephrology |
| 8 | SLE (Multi-subject cross-tested) | 2021, 2022, 2023, 2024, 2025 | 5/5 | Medicine / Pathology / Pharmacology |
| 9 | Pharmacology - Antimicrobials | 2021, 2022, 2023, 2024, 2025 | 5/5 | Pharmacology |
| 10 | Neoplasia / Tumor Markers & Suppressor Genes | 2020, 2021, 2022, 2023, 2024 | 5/5 | Pathology |
*Count = number of paper sessions (out of 5 years) the topic appeared. Within each year, multiple questions per topic are common - ACS alone generates 3-5 questions per paper covering ECG localisation, thrombolysis windows, and post-MI management.
| Rank | Topic | Confidence % | Reasoning |
|---|---|---|---|
| 1 | Diabetes Mellitus - SGLT2 inhibitors / GLP-1 agonists + DKA vs HHS | 96% | Appeared all 5 years; 2024 KDIGO & ACC/AHA guidelines updated; newer drug class questions rising sharply |
| 2 | Acute Coronary Syndrome - Primary PCI protocols + new ACC/AHA lipid guidelines | 94% | Every single paper 2021-2025; RV infarct variant increasingly tested; guideline updates always trigger new questions |
| 3 | OBG - Labor Room Emergencies (Cord prolapse, PPH, Shoulder dystocia) | 92% | Algorithmic management questions dominate; stepwise PPH approach repeated verbatim in 2023, 2024, 2025 |
| 4 | Pharmacology - Drug Interactions (ARV + TB drugs; CVS drug combos) | 90% | 2024 saw explicit HIV-TB drug interaction question; NBEMS trend toward integrated pharmacology growing year on year |
| 5 | PSM - National Health Programmes (NTEP rebrand, RMNCH+A, HPV vaccine) | 88% | Policy updates always tested within 1-2 exam cycles; HPV vaccine additions and NHM programme targets are exam favorites |
| Topic | Most Common Question Format | Example Frame |
|---|---|---|
| Acute Coronary Syndrome | "Next best step" clinical vignette (80-120 words) | ECG shows ST elevation in II, III, aVF + RV lead changes - what is the contraindicated drug? |
| Diabetes Mellitus | Diagnosis / Drug selection clinical scenario | A 55-year-old with HbA1c 9.2%, CKD stage 3 - which drug is safest to add? (tests SGLT2 vs metformin contraindications) |
| Tuberculosis | Drug regimen & side-effect one-liner | A patient on Category II DOTS develops visual field defects - which drug is responsible? |
| Pre-eclampsia / Eclampsia | Algorithmic management MCQ | A primigravida at 34 weeks has BP 160/110, proteinuria 3+ and seizures - what is the first-line management dose? |
| Postpartum Haemorrhage | Stepwise management sequence | After delivery, uterus is atonic with 900 mL blood loss unresponsive to oxytocin - what is the next step? |
| Epidemiology / PSM | Definition or formula calculation | NMR vs IMR - identify the correct formula and denominator for each |
| AKI / CKD | KDIGO staging + indication for dialysis | A patient with AKI has K+ 6.8 mEq/L, pH 7.1, creatinine 8 - which is the BEST indication for emergent dialysis? |
| SLE | Cross-subject integration MCQ | A lupus patient develops hydroxychloroquine toxicity - which investigation is done to monitor this complication? |
| Antimicrobials (Pharmacology) | Mechanism / resistance one-liner | Which beta-lactamase is responsible for carbapenem resistance in Klebsiella? |
| Neoplasia / Tumor Markers | Image + marker association | A 60-year-old male with elevated AFP + hypoechoic liver lesion on USG - next investigation? |
From the Marrow source
Marrow NEET PG previous year question analysis top recurring topics 2020 2021 2022 2023 2024 2025
marrow.ac.in NEET PG PYQ topic frequency analysis high yield subjects
https://www.marrow.com
| Marrow Feature | What It Does |
|---|---|
| QBank - 60-30-10 model | 60% clinical questions, 30% application-based, 10% one-liners - mirrors NBE's actual paper split |
| "Schema" module | All important topics in one place - their curated high-yield map (app-only) |
| Magic Module | Most-likely-to-repeat questions selected by Marrow faculty (app-only) |
| Recall videos | 2023, 2025 recall breakdowns available on YouTube (Marrow NEET PG 2025 Recall playlist) |
From YouTube videos pull last 5 year pyqs
analyse_media tool I have works only on direct image or video file URLs (.mp4, .jpg, etc.) - not on YouTube watch pages, which are JavaScript-rendered and require a logged-in session to access video streams."Marrow NEET PG 2025 recall" on YouTube"Marrow NEET PG 2024 recall""Marrow NEET PG 2023 recall"